Literature DB >> 28401000

MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway.

Fang Wu1, Jun Li2, Ni Guo1, Xiao-Hui Wang1, Yu-Qian Liao3.   

Abstract

This study aims to elucidate the effects of microRNA-27a (miR-27a) on the proliferation and invasion of gastric cancer (GC) cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. GC and normal adjacent tissues were collected from 273 GC patients. Human gastric cancer cell line (MGC803) and normal human gastric mucosal cell line (GES-1) were cultured. The miR-27a mRNA expression was analyzed using Quantitative real-time polymerase chain reaction (qRT-PCR). Immunohistochemistry (IHC) test was used to detect miR-27a and SFRP1 protein expressions. After transfection, cells were divided into five groups: the negative control (NC) group, the miR-27a inhibitor group, the miR-27a mimics group, the miR-27a inhibitor + SFRP1 siRNA group and the miR-27a mimics + SFRP1 overexpression group. Western blotting was conducted to test SFRP1 and Wnt/β-catenin protein expression. Analysis for the target gene of miR-27a was performed using Luciferase assay. Cell proliferation, migration and invasion were determined by CCK8 and Transwell assay. The dual-luciferase reporter assay system was applied to analyze the effects of miR-27a on Wnt/β-catenin signaling pathway. In GC tissue and cell line, miR-27a protein and mRNA expressions were up-regulated, and SFRP1 protein and mRNA expressions were down-regulated. Luciferase assay indicated that miR-27a might target SFRP1 and regulate its expressions. When miR-27a was down-regulated, SFRP1 was up-regulated, and β-catenin, Wnt, p-β-catenin, and p-Wnt were significantly down-regulated. Compared with the NC group, the proliferation, migration and invasion of GC cells were remarkably increased in the miR-27a group, but these were declined in the miR-27a mimics + SFRP1 overexpression group. The proliferation, migration and invasion of GC cells were elevated in the miR-27a inhibitor + SFRP1 siRNA group compared with the miR-27a inhibitor group. These results showed that miR-27a was highly expressed in GC tissues and cells, and it might promote cell proliferation, migration and invasion by targeting SFRP1 via the activation of Wnt/β-catenin signaling pathway.

Entities:  

Keywords:  MGC803 cells; MicroRNA-27a; SFRP1; Wnt/β-catenin signaling pathway; gastric cancer; invasion; migration; proliferation

Year:  2017        PMID: 28401000      PMCID: PMC5385632     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  34 in total

1.  MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.

Authors:  Xiangrong Li; Susanne U Mertens-Talcott; Shu Zhang; Kyounghyun Kim; Judith Ball; Stephen Safe
Journal:  Endocrinology       Date:  2010-04-09       Impact factor: 4.736

2.  [T Cell Factor 4, beta-catenin and SFRP1 Expression of Wnt Signaling Pathway in Colorectal Carcinoma and the Prognosis].

Authors:  Yurong Ou; Guiying Jing; Juan Liu; Shan Gao; Zenong Cheng; Xiuqin Dong
Journal:  Sheng Wu Yi Xue Gong Cheng Xue Za Zhi       Date:  2015-08

3.  A predicted miR-27a-mediated network identifies a signature of glioma.

Authors:  Shuxu Yang; Kun Wang; Cong Qian; Zhengfei Song; Peiyu Pu; Anling Zhang; Wei Wang; Huanjiang Niu; Xinwei Li; Xuchen Qi; Yinxin Zhu; Yirong Wang
Journal:  Oncol Rep       Date:  2012-08-07       Impact factor: 3.906

Review 4.  Progress in microRNA delivery.

Authors:  Yu Zhang; Zaijie Wang; Richard A Gemeinhart
Journal:  J Control Release       Date:  2013-09-25       Impact factor: 9.776

5.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

6.  Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma.

Authors:  Tsuyoshi Saito; Hiroyuki Mitomi; Abdukadir Imamhasan; Takuo Hayashi; Keiko Mitani; Michiko Takahashi; Yoshiaki Kajiyama; Takashi Yao
Journal:  Virchows Arch       Date:  2014-01-26       Impact factor: 4.064

7.  Association between five common polymorphisms in microRNA genes and the risk of gastric cancer: a meta-analysis.

Authors:  Y P Gu; Q Y Yuan; H Zhang; C J Wang; F Zhou
Journal:  Genet Mol Res       Date:  2015-07-28

Review 8.  Green tea and the risk of gastric cancer: epidemiological evidence.

Authors:  I-Chun Hou; Saral Amarnani; Mok T Chong; Anupam Bishayee
Journal:  World J Gastroenterol       Date:  2013-06-28       Impact factor: 5.742

Review 9.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

10.  CdSe/ZnS Quantum Dot-Labeled Lateral Flow Strips for Rapid and Quantitative Detection of Gastric Cancer Carbohydrate Antigen 72-4.

Authors:  Xinyu Yan; Kan Wang; Wenting Lu; Weijian Qin; Daxiang Cui; Jinghua He
Journal:  Nanoscale Res Lett       Date:  2016-03-11       Impact factor: 4.703

View more
  21 in total

1.  Knockdown of lncRNA TP73-AS1 inhibits gastric cancer cell proliferation and invasion via the WNT/β-catenin signaling pathway.

Authors:  Yufeng Wang; Shuai Xiao; Bingyi Wang; Yang Li; Quanning Chen
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

2.  Serum-derived extracellular vesicles mediate Smad4 expression through shuttling microRNA-27a in the progression of laryngeal squamous cell carcinoma.

Authors:  Yu Shuang; Xiaofeng Yao; Jing Liu; Juntao Niu; Wenyu Guo; Chao Li
Journal:  Hum Cell       Date:  2022-05-12       Impact factor: 4.174

3.  Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer.

Authors:  Jiaxin Liu; Zhao Liu; Xiaozhi Zhang; Yanli Yan; Shuai Shao; Demao Yao; Tuotuo Gong
Journal:  Cancer Cell Int       Date:  2020-07-27       Impact factor: 5.722

4.  Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p.

Authors:  Haicong Chen; Tianfeng Liu; Hanbin Ouyang; Sien Lin; Huan Zhong; Hongwu Zhang; Yang Yang
Journal:  Onco Targets Ther       Date:  2020-07-23       Impact factor: 4.147

Review 5.  MicroRNAs are involved in the development and progression of gastric cancer.

Authors:  Xiaolin Liu; Ruixia Ma; Bin Yi; Adam I Riker; Yaguang Xi
Journal:  Acta Pharmacol Sin       Date:  2020-10-09       Impact factor: 7.169

6.  MicroRNA‑4284 promotes gastric cancer tumorigenicity by targeting ten-eleven translocation 1.

Authors:  Yansen Li; Zhanlong Shen; Hongpeng Jiang; Zhiyong Lai; Zhu Wang; Kewei Jiang; Yingjiang Ye; Shan Wang
Journal:  Mol Med Rep       Date:  2018-03-01       Impact factor: 2.952

7.  MicroRNA-140-5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/β-catenin signaling pathway.

Authors:  Yinlian Cha; Ying He; Kaobin Ouyang; Hailin Xiong; Jun Li; Xia Yuan
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

8.  An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.

Authors:  Lihua Qi; Yangyang Song; Tim Hon Man Chan; Henry Yang; Chi Ho Lin; Daryl Jin Tai Tay; HuiQi Hong; Sze Jing Tang; Kar Tong Tan; Xi Xiao Huang; Jaymie Siqi Lin; Vanessa Hui En Ng; Julien Jean Pierre Maury; Daniel G Tenen; Leilei Chen
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

9.  Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis.

Authors:  Li-Dong Zu; Xing-Chun Peng; Zhi Zeng; Jing-Long Wang; Li-Li Meng; Wei-Wei Shen; Chun-Ting Hu; Ye Yang; Guo-Hui Fu
Journal:  J Exp Clin Cancer Res       Date:  2018-06-04

10.  Long non‑coding RNA NNT‑AS1 knockdown represses the progression of gastric cancer via modulating the miR‑142‑5p/SOX4/Wnt/β‑catenin signaling pathway.

Authors:  Jianfeng Zhang; Kai Zhang; Yingkui Hou
Journal:  Mol Med Rep       Date:  2020-05-18       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.